Satoru Yoshihiro

881 total citations
34 papers, 608 citations indexed

About

Satoru Yoshihiro is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Satoru Yoshihiro has authored 34 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Satoru Yoshihiro's work include Bladder and Urothelial Cancer Treatments (13 papers), Prostate Cancer Treatment and Research (8 papers) and Urinary and Genital Oncology Studies (7 papers). Satoru Yoshihiro is often cited by papers focused on Bladder and Urothelial Cancer Treatments (13 papers), Prostate Cancer Treatment and Research (8 papers) and Urinary and Genital Oncology Studies (7 papers). Satoru Yoshihiro collaborates with scholars based in Japan, Greece and Sweden. Satoru Yoshihiro's co-authors include Hideyasu Matsuyama, Katsusuke Naito, Kenji Matsuda, Peter Ekman, Yi Pan, Ulf S.R. Bergerheim, Hiroshi Hirata, Yasukazu Ohmoto, Shigeru Sakano and Chietaka Ohmi and has published in prestigious journals such as Clinical Cancer Research, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Satoru Yoshihiro

33 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoru Yoshihiro Japan 15 260 254 171 168 146 34 608
Shigeru Sakano Japan 16 436 1.7× 338 1.3× 132 0.8× 187 1.1× 234 1.6× 57 823
Peter Elfving Sweden 14 175 0.7× 288 1.1× 205 1.2× 250 1.5× 99 0.7× 26 582
Alberto Comino Italy 11 140 0.5× 319 1.3× 118 0.7× 85 0.5× 430 2.9× 20 704
Jean Kao United States 10 98 0.4× 286 1.1× 136 0.8× 249 1.5× 69 0.5× 12 559
Franck Monnien France 15 135 0.5× 212 0.8× 86 0.5× 74 0.4× 205 1.4× 38 597
Malti Kshirsagar United States 9 94 0.4× 201 0.8× 176 1.0× 151 0.9× 218 1.5× 9 603
A. S. Sarkis United States 8 632 2.4× 360 1.4× 145 0.8× 175 1.0× 419 2.9× 12 1.0k
Kumaran Mudaliar United States 11 82 0.3× 168 0.7× 110 0.6× 335 2.0× 117 0.8× 37 531
Mina Waraya Japan 15 124 0.5× 279 1.1× 122 0.7× 79 0.5× 196 1.3× 30 514
Robert T. Sweeney United States 11 51 0.2× 289 1.1× 305 1.8× 115 0.7× 95 0.7× 15 519

Countries citing papers authored by Satoru Yoshihiro

Since Specialization
Citations

This map shows the geographic impact of Satoru Yoshihiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Yoshihiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Yoshihiro more than expected).

Fields of papers citing papers by Satoru Yoshihiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Yoshihiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Yoshihiro. The network helps show where Satoru Yoshihiro may publish in the future.

Co-authorship network of co-authors of Satoru Yoshihiro

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Yoshihiro. A scholar is included among the top collaborators of Satoru Yoshihiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Yoshihiro. Satoru Yoshihiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Nagao, Kazuhiro, Hideyasu Matsuyama, Hiroaki Matsumoto, et al.. (2018). Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?. International Journal of Clinical Oncology. 23(4). 757–764. 6 indexed citations
4.
Hara, Tomohiko, Hideyasu Matsuyama, Yoriaki Kamiryo, et al.. (2015). Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer. International Journal of Clinical Oncology. 21(1). 139–147. 29 indexed citations
5.
Sakano, Shigeru, Hideyasu Matsuyama, Yoriaki Kamiryo, et al.. (2014). Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma. International Journal of Clinical Oncology. 20(2). 362–368. 32 indexed citations
6.
Shimabukuro, Tomoyuki, Shigeru Sakano, Kenji Matsuda, et al.. (2011). Can docetaxel therapy improve overall survival from primary therapy compared with androgen-deprivation therapy alone in Japanese patients with castration-resistant prostate cancer? A multi-institutional cooperative study. International Journal of Clinical Oncology. 18(1). 62–67. 13 indexed citations
7.
Matsuyama, Hideyasu, Kenji Matsuda, Satoru Yoshihiro, et al.. (2007). Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer. Cancer Genetics and Cytogenetics. 174(1). 24–34. 3 indexed citations
8.
Matsuyama, Hideyasu, Hiroshi Hirata, Kazuhiro Nagao, et al.. (2005). Smoking may cause genetic alterations at 5q22.2∼q23.1 in clear-cell renal cell carcinoma. Cancer Genetics and Cytogenetics. 163(1). 7–11. 5 indexed citations
9.
Nagao, Kazuhiro, et al.. (2005). Allelic loss of 3p25 associated with alterations of 5q22.3∼q23.2 may affect the prognosis of conventional renal cell carcinoma. Cancer Genetics and Cytogenetics. 160(1). 43–48. 14 indexed citations
10.
Matsuyama, Hideyasu, Hiroshi Hirata, Takashi Wada, et al.. (2005). Clinical significance of lymph node dissection in renal cell carcinoma. Scandinavian Journal of Urology and Nephrology. 39(1). 30–35. 11 indexed citations
11.
Yano, Seiji, Hideyasu Matsuyama, Kenji Matsuda, et al.. (2004). Accuracy of an array comparative genomic hybridization (CGH) technique in detecting DNA copy number aberrations: comparison with conventional CGH and loss of heterozygosity analysis in prostate cancer. Cancer Genetics and Cytogenetics. 150(2). 122–127. 21 indexed citations
12.
Matsuda, Kenji, Hideyasu Matsuyama, Tomohiko Hara, et al.. (2004). DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries. Cancer Genetics and Cytogenetics. 152(2). 119–123. 14 indexed citations
13.
Matsuyama, Hideyasu, Yi Pan, Satoru Yoshihiro, et al.. (2003). The Role of Chromosome 8p22 Deletion for Predicting Disease Progression and Pathological Staging in Prostate Cancer. Aktuelle Urologie. 34(4). 247–249. 9 indexed citations
14.
Hirata, Hiroshi, Katsusuke Naito, Satoru Yoshihiro, et al.. (2003). A single nucleotide polymorphism in the matrix metalloproteinase‐1 promoter is associated with conventional renal cell carcinoma. International Journal of Cancer. 106(3). 372–374. 52 indexed citations
15.
Wada, Takashi, et al.. (2002). Renal cell carcinoma: Allelic loss at chromosome 9 using the fluorescent multiplex–polymerase chain reaction technique. Human Pathology. 33(9). 910–914. 6 indexed citations
16.
Shiraishi, Koji, Masahiro Tsuchida, Takashi Wada, et al.. (2001). 22-Oxacalcitriol Upregulates p21<i><sup>WAF1/Cip1</sup></i> in Human Parathyroid Glands. American Journal of Nephrology. 21(6). 507–511. 3 indexed citations
17.
Matsuyama, Hideyasu, Satoru Yoshihiro, Fumio Kishi, et al.. (2001). Two putative tumor suppressor genes on chromosome arm 8p may play different roles in prostate cancer. Cancer Genetics and Cytogenetics. 124(1). 20–26. 38 indexed citations
18.
Matsuyama, Hideyasu, Yi Pan, Satoru Yoshihiro, et al.. (2001). Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.. PubMed. 7(10). 3139–43. 38 indexed citations
19.
Matsuyama, Hideyasu, Mitsutaka Yamamoto, Satoru Yoshihiro, Yasukazu Ohmoto, & Katsusuke Naito. (1997). Efficacy of Continuous Subcutaneous Infusion Therapy Using Interferon α and the Possible Prognostic Indicator of TNF‐α in Renal Cell Carcinoma. International Journal of Urology. 4(5). 447–450. 2 indexed citations
20.
Matsuyama, Hideyasu, Norio Yamamoto, Tomoyuki Shimabukuro, et al.. (1991). ANGIOGRAPHIC ANALYSIS OF INTRATUMORAL Pt CONCENTRATION ON INTRA-ARTERIAL INFUSION THERAPY FOR BLADDER CANCER. The Japanese Journal of Urology. 82(7). 1142–1149. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigeru Sakano Breakdown of academic impact, for papers by Peter Elfving Breakdown of academic impact, for papers by Alberto Comino Breakdown of academic impact, for papers by Jean Kao Breakdown of academic impact, for papers by Franck Monnien Breakdown of academic impact, for papers by Malti Kshirsagar Breakdown of academic impact, for papers by A. S. Sarkis Breakdown of academic impact, for papers by Kumaran Mudaliar Breakdown of academic impact, for papers by Mina Waraya Breakdown of academic impact, for papers by Robert T. Sweeney
Rankless by CCL
2026